Close

Advanced Accelerator Applications (AAAP) NDA for Lutathera Granted FDA Priority Review

June 27, 2016 7:02 AM EDT Send to a Friend
Advanced Accelerator Applications S.A. (NASDAQ: AAAP) announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login